BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22118836)

  • 21. Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
    Tajbakhsh A; Rezaee M; Rivandi M; Forouzanfar F; Afzaljavan F; Pasdar A
    Clin Biochem; 2017 Dec; 50(18):1298-1305. PubMed ID: 28779954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
    Nguyen SD; Sok DE
    Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
    Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
    Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The paraoxonase 1, 2 and 3 in humans.
    Rajkovic MG; Rumora L; Barisic K
    Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.
    Ota K; Suehiro T; Arii K; Ikeda Y; Kumon Y; Osaki F; Hashimoto K
    Metabolism; 2005 Feb; 54(2):142-50. PubMed ID: 15690306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic inflammation, intestine, and paraoxonase-1.
    Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
    Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
    Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
    Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
    Mackness M; Mackness B
    Free Radic Biol Med; 2004 Nov; 37(9):1317-23. PubMed ID: 15454272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
    Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA
    J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
    Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
    Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity.
    Mackness M; Mackness B
    Clin Biochem; 2011 Oct; 44(14-15):1270-1. PubMed ID: 21854764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.
    Deakin SP; James RW
    Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycation of human high density lipoprotein by methylglyoxal: effect on HDL-paraoxonase activity.
    Bacchetti T; Masciangelo S; Armeni T; Bicchiega V; Ferretti G
    Metabolism; 2014 Mar; 63(3):307-11. PubMed ID: 24360750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
    Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
    Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
    Rozenberg O; Aviram M
    Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes.
    Ikeda Y; Suehiro T; Arii K; Kumon Y; Hashimoto K
    Metabolism; 2008 Dec; 57(12):1725-32. PubMed ID: 19013297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress.
    Deakin SP; Bioletto S; Bochaton-Piallat ML; James RW
    Free Radic Biol Med; 2011 Jan; 50(1):102-9. PubMed ID: 20850524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
    Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.